15875350

Source:http://linkedlifedata.com/resource/pubmed/id/15875350

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010164, umls-concept:C0013227, umls-concept:C0016452, umls-concept:C0680532, umls-concept:C1551336
pubmed:issue	4
pubmed:dateCreated	2005-5-5
pubmed:abstractText	This article updates the author's previously published article on the topic, provides some insight into recent events in this area of the law, and specifies a few minor items that were noted incorrectly in the earlier work.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15875350-15298013, http://linkedlifedata.com/resource/pubmed/commentcorrection/15875350-17444026
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9215384
pubmed:citationSubset	T
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Drugs, Investigational
pubmed:status	MEDLINE
pubmed:issn	1064-590X
pubmed:author	pubmed-author:LietzanErika KingEK
pubmed:issnType	Print
pubmed:volume	59
pubmed:owner	HSR
pubmed:authorsComplete	Y
pubmed:pagination	459-63
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15875350-Drugs, Investigational, pubmed-meshheading:15875350-Humans, pubmed-meshheading:15875350-Investigational New Drug Application, pubmed-meshheading:15875350-Legislation, Drug, pubmed-meshheading:15875350-Marketing of Health Services, pubmed-meshheading:15875350-Patents as Topic, pubmed-meshheading:15875350-United States, pubmed-meshheading:15875350-United States Food and Drug Administration
pubmed:year	2004
pubmed:articleTitle	2004 update--180-day exclusivity under the Hatch-Waxman amendments to the federal Food, Drug, and Cosmetic Act.
pubmed:affiliation	Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, D.C., USA.
pubmed:publicationType	Journal Article, Comment